FCF1P11: A Drug Target / Disease Biomarker (G100132310)

Target Name: FCF1P11

NCBI ID: G100132310

FCF1P11

Other Name(s): FCF1 pseudogene 11

FCF1P11: A Drug Target / Disease Biomarker

FCF1P11 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of G-protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation.

FCF1P11 is a 11-kDa protein that is expressed in the brain, heart, and kidneys. It is localized to the dendrites of neurons and the intercellular junctions of epithelial cells. FCF1P11 is involved in a wide range of physiological processes, including neurotransmitter signaling, ion channels, and cell signaling.

One of the key functions of FCF1P11 is its role in neurotransmission. FCF1P11 is involved in the release of neurotransmitters, such as dopamine, norepinephrine, and serotonin. These neurotransmitters play a crucial role in brain function, including motivation, emotion, and memory.

In addition to its role in neurotransmission, FCF1P11 is also involved in cell signaling. It is a member of the GPCR family, which is involved in a wide range of cellular signaling processes. FCF1P11 is involved in the regulation of ion channels, which are responsible for the flow of electrical current through cells.

FCF1P11 is also involved in the regulation of cell adhesion. It is a member of the cadherin family, which is involved in cell-cell adhesion. FCF1P11 is involved in the regulation of cadherin interactions, which are important for the maintenance of tissue structure and the development of organs.

FCF1P11 is also involved in the regulation of inflammation. It is a member of the nuclear factor kappa B (NFKB) signaling pathway, which is involved in the regulation of inflammation and immune responses. FCF1P11 is involved in the regulation of NFKB signaling, which is important for the development of inflammatory diseases.

In conclusion, FCF1P11 is a protein that is involved in a wide range of physiological processes, including neurotransmission, cell signaling, and inflammation. As a drug target or biomarker, FCF1P11 may be useful in the development of new treatments for a wide range of diseases, including neurodegenerative diseases, psychiatric disorders, and inflammatory diseases.

Protein Name: FCF1 Pseudogene 11

The "FCF1P11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FCF1P11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets